KAITLIN SULLIVAN: Open Payments
NPI 1710238001 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 25 payments from 17 companies in 2025. Trend: 2023 $367 · 2024 $690 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $88 |
| Radius Health, Inc. | 2 | $41 |
| Biogen, Inc. | 2 | $38 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $33 |
| Novo Nordisk Inc | 2 | $32 |
| MILLICENT US INC | 2 | $31 |
| ABBVIE INC. | 1 | $28 |
| Abbott Laboratories | 1 | $24 |
| Bracco Diagnostics Inc. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $19 |
Products named: Veozah, Tymlos, ZURZUVAE, Wegovy, INTRAROSA, BOTOX, FREESTYLE LIBRE 3, Vueway (gadopiclenol).
Industry payments across KY — which companies pay providers there.
